首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells.
【24h】

Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells.

机译:分析富含造血干/祖细胞的人和小鼠骨髓细胞上的糖蛋白E-选择蛋白配体。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Although well recognized that expression of E-selectin on marrow microvessels mediates osteotropism of hematopoietic stem/progenitor cells (HSPCs), our knowledge regarding the cognate E-selectin ligand(s) on HSPCs is incomplete. Flow cytometry using E-selectin-Ig chimera (E-Ig) shows that human marrow cells enriched for HSPCs (CD34(+) cells) display greater E-selectin binding than those obtained from mouse (lin(-)/Sca-1(+)/c-kit(+) [LSK] cells). To define the relevant glycoprotein E-selectin ligands, lysates from human CD34(+) and KG1a cells and from mouse LSK cells were immunoprecipitated using E-Ig and resolved by Western blot using E-Ig. In both human and mouse cells, E-selectin ligand reactivity was observed at ~ 120- to 130-kDa region, which contained two E-selectin ligands, the P-selectin glycoprotein ligand-1 glycoform "CLA," and CD43. Human, but not mouse, cells displayed a prominent ~ 100-kDa band, exclusively comprising the CD44 glycoform "HCELL." E-Ig reactivity was most prominent on CLA in mouse cells and on HCELL in human cells. To further assess HCELL's contribution to E-selectin adherence, complementary studies were performed to silence (via CD44 siRNA) or enforce its expression (via exoglycosylation). Under physiologic shear conditions, CD44/HCELL-silenced human cells showed striking decreases (> 50%) in E-selectin binding. Conversely, enforced HCELL expression of LSK cells profoundly increased E-selectin adherence, yielding > 3-fold more marrow homing in vivo. These data define the key glycoprotein E-selectin ligands of human and mouse HSPCs, unveiling critical species-intrinsic differences in both the identity and activity of these structures.
机译:尽管众所周知,E-选择蛋白在骨髓微血管上的表达介导造血干/祖细胞(HSPC)的向骨性,但我们对HSPC上同源E-选择蛋白配体的了解并不完整。使用E-选择素-Ig嵌合体(E-Ig)的流式细胞仪显示,富集HSPC的人骨髓细胞(CD34(+)细胞)比从小鼠(lin(-)/ Sca-1( +)/ c-kit(+)[LSK]单元)。为了定义相关的糖蛋白E-选择素配体,使用E-Ig免疫沉淀人CD34(+)和KG1a细胞和小鼠LSK细胞的裂解物,并使用E-Ig通过Western blot进行解析。在人和小鼠细胞中,在约120-130 kDa的区域均观察到E-选择蛋白配体的反应性,其中包含两个E-选择蛋白配体,即P-选择蛋白糖蛋白配体-1糖型“ CLA”和CD43。人细胞而非小鼠细胞显示出显着的〜100 kDa条带,仅包含CD44糖型“ HCELL”。 E-Ig反应性在小鼠细胞中的CLA和人细胞中的HCELL中最为突出。为了进一步评估HCELL对E-选择素依从性的贡献,进行了补充研究以沉默(通过CD44 siRNA)或增强其表达(通过外糖基化)。在生理剪切条件下,CD44 / HCELL沉默的人类细胞显示E-选择素结合显着下降(> 50%)。相反,LSK细胞的HCELL强制表达大大增加了E-选择素的粘附,在体内产生的骨髓归巢率高出3倍以上。这些数据定义了人类和小鼠HSPC的关键糖蛋白E-选择蛋白配体,揭示了这些结构的身份和活性方面关键的物种内在差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号